ARANTXA
ISLA RUIZ
![Foto de ARANTXA](/img/nophoto.png)
![Foto de Universidad del País Vasco/Euskal Herriko Unibertsitatea](/img/noimage_org.png)
Universidad del País Vasco/Euskal Herriko Unibertsitatea
Lejona, EspañaPublicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (57)
2023
-
Ceftaroline and Avibactam Removal by Continuous Renal Replacement Therapies: An in vitro Study
Blood Purification, Vol. 52, Núm. 5, pp. 464-473
-
Modelo SoTL para evaluar el aprendizaje basado en la investigación en el desarrollo de TFG sobre atención farmacéutica
XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones
-
Pharmacokinetic/Pharmacodynamic Analysis of Oral Calcium Fosfomycin: Are Urine Levels Sufficient to Ensure Efficacy for Urinary Tract Infections?
Pharmaceutics, Vol. 15, Núm. 4
2022
-
Key Factors in Effective Patient-Tailored Dosing of Fluoroquinolones in Urological Infections: Interindividual Pharmacokinetic and Pharmacodynamic Variability
Antibiotics, Vol. 11, Núm. 5
-
Oferta de servicios de atención farmacéutica: clave para un nuevo modelo de servicios de salud = Supply of pharmaceutical care services: The key to a new model of health services
Atención Primaria, Vol. 54, Núm. 1, pp. 102-198
-
Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study
Journal of Intensive Care, Vol. 10, Núm. 1
2021
-
Evaluation of the adequacy of the antimicrobial therapy of invasive Haemophilus influenzae infections: A pharmacokinetic/pharmacodynamic perspective
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 2, pp. 65-71
-
Farmazia-zerbitzu profesional asistentzialak Euskal Autonomia Erkidegoko (EAE) farmazietan
Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 39, pp. 131-152
-
Pharmacokinetic/pharmacodynamic evaluation of the antimicrobial therapy of pneumococcal invasive disease in adults in post-PCV13 vaccine period in Madrid, Spain
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 10, pp. 2145-2152
-
Pharmacotherapeutic management of Parkinson's disease inpatients: How about asking hospital pharmacists?
European Journal of Hospital Pharmacy, Vol. 28, Núm. e1, pp. E140-E145
-
Population pharmacokinetics of levetiracetam and dosing evaluation in critically ill patients with normal or augmented renal function
Pharmaceutics, Vol. 13, Núm. 10
-
Pseudomonas aeruginosa susceptibility in spain: Antimicrobial activity and resistance suppression evaluation by pk/pd analysis
Pharmaceutics, Vol. 13, Núm. 11
-
Quantification of ceftaroline in human plasma using high‐performance liquid chromatography with ultraviolet detection: Application to pharmacokinetic studies
Pharmaceutics, Vol. 13, Núm. 7
-
The role of pk/pd analysis in the development and evaluation of antimicrobials
Pharmaceutics, Vol. 13, Núm. 6
2020
-
Aprendizaje basado en la investigación/indagación para el desarrollo de TFG de Farmacia
Conference proceedings CIVINEDU 2020: 4th International Virtual Conference on Educational Research and Innovation September 23-24, 2020
-
Impact of augmented renal clearance on the pharmacokinetics of linezolid: Advantages of continuous infusion from a pharmacokinetic/pharmacodynamic perspective
International Journal of Infectious Diseases, Vol. 93, pp. 329-338
-
Novel population pharmacokinetic model for linezolid in critically ill patients and evaluation of the adequacy of the current dosing recommendation
Pharmaceutics, Vol. 12, Núm. 1
2019
-
Application of pharmacokinetic/pharmacodynamic analysis to evaluate the adequacy of antimicrobial therapy for pediatric acute otitis media in Spain before and after the introduction of the PCV7 vaccine
Revista Espanola de Quimioterapia, Vol. 32, Núm. 2, pp. 121-129
-
Pharmacokinetic/pharmacodynamic analysis as a tool for surveillance of the activity of antimicrobials against Pseudomonas aeruginosa strains isolated in critically ill patients
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 6, pp. 380-386
-
Pharmacokinetics of linezolid in critically ill patients on continuous renal replacement therapy: Influence of residual renal function on PK/PD target attainment
Journal of Critical Care, Vol. 50, pp. 69-76